Bedside rapid diagnostics or will become a new medical trend

Release date: 2009-02-19



A groundbreaking study released this month in the prestigious medical journal *Emergency Medical Yearbook* highlights how advanced bedside rapid diagnostic tools are transforming emergency care. The research, led by Dr. Richard Ryan from the University of Cincinnati Medical School, found that using these devices can significantly reduce the time it takes to diagnose chest pain, potentially saving critical minutes for patients suffering from heart-related conditions.

The study, titled *"Multi-channel Randomized Control of Central Laboratory and Rapid Diagnosis of Cardiac Disease Detection Strategies: The Impact of Rapid Diagnostic Marks in the Acute Coronary Syndrome Test Series"*, involved a large-scale clinical trial with 2000 patients experiencing chest pain or suspected acute coronary syndrome. Conducted across four top-tier emergency departments—Jewish Hospital in Cincinnati, William Beaumont Hospital in Detroit, the University of Pennsylvania, and Stanford University—the research compared traditional lab procedures with the use of the Abbott i-STAT device.

Unlike the conventional "emergency room-laboratory-emergency room" process, which often leads to delays, the i-STAT system provides instant laboratory-quality results within 20 to 45 minutes. This speed is crucial, as guidelines from the American Heart Association, European Heart Association, and the National Association of Clinical Biochemistry emphasize that blood testing should be completed within 60 minutes, ideally in under 30 minutes.

"Time is everything when it comes to heart attacks," said Dr. Christopher J. Lindsell, one of the researchers at the University of Cincinnati Medical Center. "The i-STAT device represents a major shift in how we approach emergency diagnostics. It enables faster decision-making and better patient outcomes."

This innovation not only improves efficiency but also sets a new standard in emergency medicine, paving the way for more real-time, patient-centered care. As the field continues to evolve, such technologies will play an increasingly vital role in saving lives during critical moments.

—Shanghai Medical Device Industry Association

Food Additive Fructose Syrup

Food Additive Fructose Syrup,Fructose Corn Syrup Strain,Glucose Fructose Syrup,Fructose Syrup Enzymes

JILIN COFCO BIO-CHEM AND BIO-ENERGY MARKETING CO., LTD , https://www.cofco-biotech.com